Dr. Lal Path Labs Ltd.
NSE: LALPATHLABINE600L01024·HealthcareSmallcap 250·www.lalpathlabs.com ↗·Mcap ₹32,271 Cr·Listed 2015
₹1,952.30▼ ₹9.00  (−0.46%)
52W: ₹1,273 – ₹2,039 · Vol: 4.5L shares · Close 25 Sept
Set Alert

Quarterly results

consolidated · as filed with NSE · Q1 FY27 back to Q4 FY18
₹ croreQ1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25Q2 FY25Q1 FY25Q4 FY24Q3 FY24Q2 FY24Q1 FY24Q4 FY23Q3 FY23Q2 FY23Q1 FY23Q4 FY22Q2 FY22Q1 FY22Q4 FY21Q3 FY21Q2 FY21Q1 FY21Q4 FY20Q3 FY20Q2 FY20Q1 FY20Q4 FY19Q3 FY19Q2 FY19Q1 FY19Q4 FY18
Revenue from operations798703660731670603597660602545539601541491489534503486498607431452432266302328366335301293318292267
Other income31.92424.424.828.125.825.121.920.618.418.318.114.414.210.58.78.31214.314.113.513.512.911.41213.814.814.413.512.210.99.48.9
Total expenses601567530552517475484499473444441467438422423440430414382441334337328239268268278260245237240226214
EBITDA24818717922419216915420317014514117814611611314411812114218912213912748.357.382.310995.166.265.686.87564
EBITDA margin31.0%26.6%27.2%30.7%28.7%28.0%25.8%30.7%28.2%26.5%26.1%29.6%27.0%23.5%23.1%26.9%23.4%24.9%28.4%31.2%28.3%30.7%29.5%18.2%19.0%25.1%29.8%28.4%22.0%22.4%27.3%25.7%24.0%
Finance costs6.36.17.24.84.755.3666.677.8899.110.98.511.94.74.64.43.943.73.93.93.73.80.10.30.20.20.2
Depreciation44.444.642.140.534.636.435.535.334.736.63635.935.137.637.938.835.937.720.519.220.319.519.517.92018.817.716.310.49.69.48.810.7
Profit before tax22916012420418115313818315012011615211883.276.510381.483.513117911112911738.145.473.410289.469.267.988.175.462
Tax58.227.932.951.447.1−2.140.252.342.134.133.741.533.926.322.930.423.221.434.345.625.73329.59.712.818.521.330.321.821.830.725.721.8
Net profit17113291.415213415698.113110885.882.211183.656.953.672.458.262.196.313485.195.987.128.432.654.98159.147.446.157.449.740.2
Net margin21.4%18.8%13.9%20.8%20.0%25.8%16.4%19.8%17.9%15.7%15.3%18.4%15.5%11.6%11.0%13.6%11.6%12.8%19.3%22.0%19.7%21.2%20.2%10.7%10.8%16.7%22.2%17.6%15.7%15.8%18.1%17.0%15.1%
EPS (₹)10.157.865.4218.0515.8818.5711.6015.5212.7910.139.7713.169.956.846.378.646.977.4111.4915.8710.1011.4410.343.453.946.569.777.145.725.566.926.004.88
Net profit YoY+27.2%−15.0%−6.8%+16.4%+24.3%+81.2%+19.3%+18.2%+28.9%+50.8%+53.4%+52.9%+43.6%−8.4%–−24.8%−56.5%−27.0%+10.6%+370.8%+161.0%+74.7%+7.5%−51.9%−31.2%+19.1%+41.1%+18.9%+17.9%––––

Annual results

financial years ending March · from the fourth-quarter filings
₹ croreFY26FY25FY24FY23FY22FY21FY20FY19FY18
Revenue from operations2,7632,4612,2272,0172,0871,5811,3301,2031,057
Other income10193.469.241.752.551.3554631.2
Total expenses2,1651,9301,7901,7151,6651,2381,075949827
EBITDA783696609490561436344294264
EBITDA margin28.3%28.3%27.4%24.3%26.9%27.6%25.8%24.4%25.0%
Finance costs22.822.329.437.530.21615.30.80.8
Depreciation16214214415010877.272.838.233.1
Profit before tax669625506344475394311301261
Tax15913314310312597.982.910089.5
Net profit510492362241350297228201172
Net margin18.5%20.0%16.3%12.0%16.8%18.8%17.1%16.7%16.3%
EPS (₹)30.2458.4843.0528.8241.7035.3327.4224.1920.85
Net profit YoY+3.6%+35.9%+50.3%−31.2%+18.1%+30.3%+13.5%+16.7%–
EPS is as filed for each period and is not restated for later bonus issues or splits.

Cash flow

annual · ₹ crore
₹ croreFY26FY25FY24FY23FY22
Operating cash flow636569535456447
Investing cash flow−422−303−24.3−287−449
Financing cash flow−264−334−414−283136
Capital expenditure16744.351.236.594.1
Free cash flow (CFO − capex)469525484420353

Net profit trend

annual, ₹ crore
FY21
₹297
FY22
₹350+18%
FY23
₹241−31%
FY24
₹362+50%
FY25
₹492+36%
FY26
₹510+4%

Result filings

as filed with NSE · PDF and XBRL
PeriodBasisFiledDocuments
Q1 FY27Consolidated24 Jul 2026PDF on NSE XBRL
Q1 FY27Standalone24 Jul 2026PDF on NSE XBRL
Q4 FY26Consolidated · audited30 Apr 2026PDF on NSE XBRL
Q4 FY26Standalone · audited30 Apr 2026PDF on NSE XBRL
Q3 FY26Consolidated30 Jan 2026PDF on NSE XBRL
Q3 FY26Standalone30 Jan 2026PDF on NSE XBRL
Q2 FY26Consolidated31 Oct 2025PDF on NSE XBRL
Q2 FY26Standalone31 Oct 2025PDF on NSE XBRL
Q1 FY26Consolidated31 Jul 2025PDF on NSE XBRL
Q1 FY26Standalone31 Jul 2025PDF on NSE XBRL

Annual reports

NSE archive
Key ratios
P/E (TTM)5Y avg 50.3×59.9×
P/B5Y avg 11.01×13.05×
ROEFY26, on average equity21.8%
Net margin18.5%
Debt / equity0.00×
Revenue CAGR (3Y)11.1%
Profit CAGR (3Y)28.4%
EPS (TTM)₹32.60
Market cap₹32,721 Cr
Computed from the filings and the last close. Market cap uses the latest share count from the balance sheet.
P/B vs history
13.05×
vs 8-point avg 11.01× (+18%)
8.77× low11.01× avg13.83× high
History points are balance-sheet dates (2022 → 2026), priced at the adjusted close on each date.
Balance sheet 31 Mar 2026
Total assets₹3,146 Cr+16%
Net worth₹2,508 Cr+15%
Total borrowings₹0 Cr
Cash & bank balances₹243 Cr−17%
Investments₹423 Cr+29%
Inventories₹44 Cr+22%
Trade receivables₹111 Cr+26%
Trade payables₹181 Cr−9%
Change vs the same date a year earlier.
Shareholding 30 Jun 2026
%Jun 26Mar 26Dec 25Dec 25Sept 25Jun 25Mar 25Dec 24Sept 24Jun 24Mar 24Dec 23
Promoter53.1953.2153.2153.2153.2153.7953.9153.9153.9254.6054.6054.60
FII17.3617.1820.2920.6821.8621.6823.9126.8226.8225.4226.1525.35
DII21.5921.3819.2118.9618.4917.9116.0813.1712.8912.719.699.56
of which MF18.7918.6216.8416.6015.9015.04––––––
Retail6.256.555.825.725.185.234.104.014.104.916.477.26
Other public1.231.331.121.080.891.001.741.811.942.062.772.86
1,11,037 shareholders · NSE shareholding pattern filings.